The herb lobelia was originally used by Native Americans in the New England region. It was subsequently popularized by Samuel Thomson, the founder of an ideosyncratic form of medicine called Thomsonianism. The enduring popularity of lobelia is one of the legacies of this nineteenth century enthusiasm. ( Goldenseal is another herb popularized by Thomson.) The traditional names of the herb capture its traditional uses: wild tobacco, asthma weed, gagroot, and pukeweed. Dried lobelia tastes and smells somewhat like tobacco, and for this reason it was sold as a tobacco substitute. Lobelia was also used to treat asthma and stimulate vomiting.
The Thomsonians additionally claimed that lobelia could relax muscles and nerves. On this basis, they used it for anxiety, epilepsy, kidney stones, insomnia, menstrual cramps, muscle spasms, spastic colon, and tetanus.
The major active ingredient of lobelia is a substance called lobeline. It is widely stated that lobeline is chemically similar to nicotine, and on this basis it has been marketed as a stop-smoking treatment. However, this belief appears to be a type of urban legend; lobeline is not in fact chemically similar to nicotine.1
Interestingly, chemists investigating the lobeline–nicotine myth found that lobeline may diminish certain effects of nicotine in the body, specifically nicotine-induced release of the substance dopamine. Since dopamine is believed to play a significant role in drug addiction, these findings can be taken as hinting that lobeline might be useful for treating drug addiction. Potential benefits have been found for addiction to amphetamines.1,2 ,3
Dopamine also plays a role in cigarette addiction. For this reason, despite lobeline’s lack of similarity to nicotine, it is at least possible that lobelia could be helpful for people who wish to stop smokeing. Unfortunately, despite its widespread marketing for this purpose, there has never been any meaningful evidence that it works.4
Other proposed uses of lobelia also lack supporting evidence. For example, while studies in horses have found that injected lobeline causes the animals to breath more deeply,5 it is a long way from a finding like this to the widespread claims that lobelia is helpful for asthma. Similarly, animal studies hint that lobeline might enhance memory6 and reduce pain,7 and, in addition, that beta-amyrin palmitate, another constituent of lobelia, might have antidepressant and sedative properties.8-10
However, there have not yet been any human studies on these potential benefits of the herb.
Lobelia is generally sold in the form of a vinegar tincture. The typical dose of this tincture is 20 to 60 drops taken three times daily.
It is widely stated that lobelia is a dangerously toxic herb. However, herbalist Paul Bergner undertook a review of published literature and discovered that each author who described lobelia as toxic was merely quoting another author, in a kind of game of telephone going back nearly 200 years.11 The original published reference upon which this sequence of hearsay reporting appears to have been based is a note in the American New Dispensatory of 1810, in which an “eminent physician” is quoted as stating that if a person consumes lobelia and doesn’t vomit, death will follow. The ultimate origin of this claim may have been the claims made by the prosecution in a widely publicized trial of Samuel Thomson in which he was accused of committing murder through use of lobelia.
In fact, there are no reported cases of death caused by Lobelia inflata in animals or humans. Considering how widely lobelia was used under the Thomsonians and subsequently, the concern that it reliably causes death appears to be a significant overstatement. Lobelia may present health risks, but if so, they have not been documented.
Short-term side effects that have been reported in association with lobelia include stomach pain, heartburn, nausea, vomiting, and dizziness.12,13 Lobeline also appears to trigger coughing and a sense of choking, for reasons that are unclear.14-16
The fact that lobeline restricts dopamine release suggests at least a possibility that lobelia could worsen symptoms of Parkinson’s disease (in which dopamine levels are low) and possibly interfere with the action of drugs used for schizophrenia or attention deficit disorder (which also act on dopamine). These concerns are, however, purely theoretical at this time.
Safety in young children, pregnant or nursing women, or people with severe liver or kidney disease has not been established.
1. Dwoskin LP, Crooks PA. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem Pharmacol. 2002;63:89–98.
2. Miller DK, Crooks PA, Teng L, et al. Lobeline inhibits the neurochemical and behavioral effects of amphetamine. J Pharmacol Exp Ther. 2001;296:1023–34.
3. Harrod SB, Dwoskin LP, Crooks PA, Klebaur JE, Bardo MT. Lobeline attenuates d-methamphetamine self-administration in rats. J Pharmacol Exp Ther. 2001;298:172–9.
4. Davison GC, Rosen RC. Lobeline and reduction of cigarette smoking. Psychol Rep. 1972;31:443–56.
5. Marlin DJ, Roberts CA, Schroter RC, Lekeux P. Respiratory responses of mature horses to intravenous lobeline bolus. Equine Vet J. 2000;32:200–7.
6. Decker MW, Majchrzak MJ, Arneric SP. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol Biochem Behav. 1993;45:571–6.
7. Hamann SR, Martin WR. Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)-lobeline in the rat brainstem. Pharmacol Biochem Behav. 1994;47:197–201.
8. Subarnas A, Tadano T, Oshima Y, Kisara K, Ohizumi Y. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves. J Pharm Pharmacol. 1993;45:545–50.
9. Subarnas A, Tadano T, Nakahata N, et al. A possible mechanism of antidepressant activity of beta-amyrin palmitate isolated from Lobelia inflata leaves in the forced swimming test. Life Sci. 1993;52:289–96.
10. Subarnas A, Oshima Y, Sidik, Ohizumi Y. An antidepressant principle of Lobelia inflata L. (Campanulaceae). JPharm Sci. 1992;81:620–1.
11. Bergner P. Is lobelia toxic? Medical Herbalism. 1998;10:1,15–32.
12. Wright IS, Littauer D. Lobeline sulfate: its pharmacology and use in the treatment of the tobacoo habit. JAMA. 1937;109:649–654.
13. Felter HW, Lloyd JU. King’s American Dispensatory, 18th ed. Sandy, OR: Eclectic Medical Publications, 1898, 1983; 1199–205.
14. Raj H, Bakshi GS, Tiwari RR, Anand A, Paintal AS. How does lobeline injected intravenously produce a cough? Respir Physiol Neurobiol. 2005;145:79–90.
15. Butler JE, Anand A, Crawford MR, et al. Changes in respiratory sensations induced by lobeline after human bilateral lung transplantation. J Physiol. 2001;534(Pt. 2):583–93.
16. Raj H, Singh VK, Anand A, Paintal AS. Sensory origin of lobeline-induced sensations: a correlative study in man and cat. J Physiol. 1995;482(pt 1):235–46.
Last reviewed August 2013 by EBSCO CAM Review Board
Last Updated: 8/22/2013
Copyright © 2013 EBSCO Publishing All rights reserved.
Sponsored by iHerb.Com
Positively the best overall value for natural products!